Chemistry:Triazoledione

From HandWiki
Short description: Phenylpiperazine compound
Triazoledione
Triazoledione.svg
Clinical data
Other namesBMS-180492
Pharmacokinetic data
Elimination half-life18 hours[1]
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC23H28ClN5O3
Molar mass457.96 g·mol−1
3D model (JSmol)

Triazoledione (developmental code name BMS-180492) is a phenylpiperazine compound and a major metabolite of the antidepressant nefazodone.[2][3] It is active, but with substantially reduced potency compared to nefazodone (approximately one-seventh).[3][2] As such, it has been suggested that it is unlikely that triazoledione contributes significantly to the pharmacology of nefazodone.[3] However, triazoledione may reach concentrations as great as 10 times those of nefazodone, and hence could still be a significant contributor to its therapeutic effects.[2]

Pharmacology

Site Ki (nM) Species Ref
SERT ≥34,527
≥26,471
Human
Rat
[4]
[4][3]
NET >100,000
100,000
Human
Rat
[4]
DAT ND ND ND
5-HT1A 636–1,371 Rat [3][4]
5-HT2A 159–211 Rat [4][3]
5-HT2C ND ND ND
α1 173
1,000
Human
Rat
[4]
[3]
α2 1,915
1,000
Human
Rat
[4]
[3]
β >100,000 Rat [3]
H1 11 Guinea pig [4]
mACh >100,000 Rat [4]
Values are Ki (nM). The smaller the value, the more strongly the drug binds to the site.

Triazoledione shows significant affinity for the serotonin 5-HT1A and 5-HT2A receptors, the α1-adrenergic receptor, and the histamine H1 receptor.[3][4] It shows negligible affinity for the serotonin and norepinephrine transporters and the muscarinic acetylcholine receptors.[3][4]

Comparison of binding profiles of triazoledione and related compounds[3][4]
Compound 5-HT1A 5-HT2A SERT NET α1 α2 β H1 mACh
Hydroxynefazodone 56–589 7.2–34 165–1,203 376–1,053 8.0–145 63–2,490 >1,000 28 11,357
mCPP 16–411 110–433 127–432 490–4,360 97–763 112–371 4,890 449 4,702
Nefazodone 52–1,030 7.1–32 181–549 200–713 5.5–144 84–41,700 >100,000 30 4,569
Trazodone 42–288 11–20 115–690 ≥20,887 12–23 106–1,070 47,100 29 12,188
Triazoledione 636–1,371 159–211 ≥26,471 >100,000 ≥173 ≥1,915 >100,000 11 >100,000
Values are Ki (nM). The smaller the value, the more strongly the drug binds to the site.

See also

References

  1. "Trazodone and Nefazodone". The American Psychiatric Association Publishing Textbook of Psychopharmacology (Fifth ed.). American Psychiatric Pub. 2017. pp. 460–. ISBN 978-1-58562-523-9. https://books.google.com/books?id=KfHEDgAAQBAJ&pg=PA460. 
  2. 2.0 2.1 2.2 "General Principles of Pharmacokinetics". Antidepressants: Past, Present and Future. Springer Science & Business Media. 6 December 2012. pp. 68–. ISBN 978-3-642-18500-7. https://books.google.com/books?id=Ue3uCAAAQBAJ&pg=PA68. 
  3. 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 "Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression". Drugs 53 (4): 608–636. April 1997. doi:10.2165/00003495-199753040-00006. PMID 9098663. 
  4. 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 Cite error: Invalid <ref> tag; no text was provided for refs named pmid9400006